Ipsen Initiates a Share Buyback Program to Cover Its New Free Share Allocation Plan
June 18 2019 - 1:00AM
Business Wire
Regulatory News:
Ipsen (Euronext: IPN; ADR: IPSEY), announces today that it has
appointed an investment services provider to purchase 150,000 Ipsen
SA shares, or about 0.18% of the share capital, over a period of
maximum 2 months. The shares purchased under this agreement will be
mainly allocated to cover its new free employee share allocation
plan.
This program is made pursuant to the authorization granted by
the Combined Shareholders’ Meeting held on 28 May 2019.
About Ipsen
Ipsen is a global specialty-driven biopharmaceutical group
focused on innovation and Specialty Care. The group develops and
commercializes innovative medicines in three key therapeutic areas
- Oncology, Neuroscience and Rare Diseases. Its commitment to
Oncology is exemplified through its growing portfolio of key
therapies for prostate cancer, neuroendocrine tumors, renal cell
carcinoma and pancreatic cancer. Ipsen also has a well-established
Consumer Healthcare business. With total sales over €2.2billion in
2018, Ipsen sells more than 20 drugs in over 115 countries, with a
direct commercial presence in more than 30 countries. Ipsen's
R&D is focused on its innovative and differentiated
technological platforms located in the heart of the leading
biotechnological and life sciences hubs (Paris-Saclay, France;
Oxford, UK; Cambridge, US). The Group has about 5,700 employees
worldwide. Ipsen is listed in Paris (Euronext: IPN) and in the
United States through a Sponsored Level I American Depositary
Receipt program (ADR: IPSEY). For more information on Ipsen, visit
www.ipsen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190617005736/en/
For further
information:MediaChristian MarcouxSenior
Vice President, Global Communications+33 (0)1 58 33 67
94christian.marcoux@ipsen.comFanny AllaireDirector, Ipsen
France Hub, Global Communications+33 (0) 1 58 33 58
96fanny.allaire@ipsen.comFinancial
CommunityEugenia LitzVice President, Investor
Relations+44 (0) 1753 627721eugenia.litz@ipsen.comMyriam
KoutchinskyInvestor Relations Manager+33 (0)1 58 33 51
04myriam.koutchinsky@ipsen.com
Ipsen (EU:IPN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ipsen (EU:IPN)
Historical Stock Chart
From Apr 2023 to Apr 2024